Pre-market PATH (UiPath Inc., NYSE) $15.15 26 Jan 2026: AI growth test
In pre-market trading on 26 Jan 2026 the PATH stock price shows $15.15, putting UiPath Inc. (PATH) on watch for AI-driven revenue traction. The market is parsing a PE of 35.25 and EPS of 0.42 as investors weigh RPA adoption against expensive multiples. Volume is active at 20,327,906.00 shares and the next earnings date is 11 Mar 2026, both key near-term catalysts for PATH stock.
PATH stock: current price, volume and market context
UiPath Inc. (PATH) is trading on the NYSE at $15.15 in pre-market on 26 Jan 2026. Today’s intraday range sits between $14.40 low and $15.16 high, with a year range of $9.38 to $19.84. Market capitalization stands at $7,915,924,845.00 and shares outstanding are 534,679,152.00.
Average daily volume is 26,369,369.00, so the current trade of 20,327,906.00 shares shows below-average liquidity but continued investor interest. For real-time quotes and P/E context see Nasdaq and MarketBeat coverage source source.
PATH stock: fundamentals, valuation and cash metrics
UiPath’s trailing metrics show EPS 0.42 and PE 35.25, reflecting premium expectations for AI-led automation growth. Price-to-sales is 5.11 and price-to-book is 4.16, while free cash flow yield is 3.93%, indicating limited yield for value seekers.
Balance-sheet strength appears solid: cash per share is 2.59, current ratio 2.54, and debt-to-equity 0.04. These metrics support continued R&D and sales investment but argue for discipline if multiples compress.
PATH stock: growth drivers, sector positioning and risks
UiPath sits in the Technology sector, Software – Infrastructure industry, with a heavy AI and RPA positioning that drives top-line expansion. Recent growth rates show revenue growth 23.57% (FY), operating income growth 52.71%, and EPS growth 73.33%, signaling scalable margins where automation adoption increases.
Key risks: customer concentration and long receivable cycles (days sales outstanding 116.59) could pressure cash conversion. Competitive pressure from cloud AI providers and macro softness in enterprise IT spend are downside drivers for PATH stock.
PATH stock: technical outlook and trading signals
Short-term technicals are mixed: RSI at 48.95 suggests neutral momentum and ADX 18.02 implies no clear trend. Bollinger bands place the middle at 16.63 and lower at 15.35, framing $15.15 near the lower band as a tactical support level.
Traders should watch average price 50-day 15.66 and 200-day 13.38 for trend confirmation. A decisive close above $16.63 would favor continuation; a breakdown under $14.40 increases short-term volatility risk for PATH stock.
Meyka AI rates PATH with a score out of 100 and model forecast
Meyka AI rates PATH with a score out of 100: 75.51 (B+) — BUY. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. Grades are informational and not financial advice.
Meyka AI’s forecast model projects a monthly target of $14.00, a yearly target of $17.12, and a three-year target of $19.83. Compared to the current $15.15, the model implies a monthly downside of -7.59% and a 12-month upside of +13.02%. Forecasts are model-based projections and not guarantees.
PATH stock: upcoming catalysts and earnings watch
UiPath reports next on 11 Mar 2026; guidance and AI subscription mix will be the primary focus for investors. Management commentary on customer retention and seat expansion will affect PATH stock trading around the print.
Other catalysts include enterprise AI adoption metrics, partner wins, and incremental margin improvement from product mix changes. Monitor analyst updates: the current consensus leans toward 10 holds and 1 buy, with an aggregate consensus rating of 3.00.
Final Thoughts
For AI-focused investors, PATH stock offers a balanced risk-reward: the company shows strong growth metrics and a healthy balance sheet, yet carries premium multiples and working capital friction. Meyka AI’s model projects $17.12 in 12 months, implying +13.02% upside from the $15.15 pre-market price on 26 Jan 2026. Short-term pressure could push the stock toward the model monthly level of $14.00 (-7.59%), making position sizing and entry timing important. We note the consensus tilt toward Hold and encourage watching the 11 Mar 2026 earnings for revenue cadence and AI subscription traction. Meyka AI provides this AI-powered market analysis as data-driven context, not personalized investment advice.
FAQs
What is the current price and P/E of PATH stock?
PATH stock trades at $15.15 pre-market on 26 Jan 2026 with a trailing P/E of 35.25 and reported EPS of 0.42. These metrics reflect premium growth expectations in the AI automation space.
When is UiPath’s next earnings and what matters for PATH stock?
UiPath’s next earnings are set for 11 Mar 2026. Investors will watch revenue growth, AI subscription mix, retention metrics, and margin trajectory as the main drivers for PATH stock performance.
What is Meyka AI’s near-term forecast for PATH stock?
Meyka AI’s forecast model projects $14.00 monthly and $17.12 yearly for PATH stock. These are model-based projections and are not guarantees; they imply a 12-month upside of +13.02% from $15.15.
Is PATH stock a buy now according to analysts?
Analyst coverage currently shows 1 Buy and 10 Hold with a consensus rating of 3.00. Meyka AI assigns a B+ (BUY) grade, but investors should consider valuation and upcoming earnings before adding exposure to PATH stock.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
